Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease

被引:88
|
作者
Valenza, M. [1 ,2 ]
Marullo, M. [1 ,2 ]
Di Paolo, E. [1 ,2 ]
Cesana, E. [3 ]
Zuccato, C. [1 ,2 ]
Biella, G. [3 ]
Cattaneo, E. [1 ,2 ]
机构
[1] Univ Milan, Dept Biosci, I-20133 Milan, Italy
[2] Univ Milan, Ctr Stem Cell Res, I-20133 Milan, Italy
[3] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy
来源
CELL DEATH AND DIFFERENTIATION | 2015年 / 22卷 / 04期
关键词
CENTRAL-NERVOUS-SYSTEM; GLIAL-CELLS; MUTANT HUNTINGTIN; MOUSE MODEL; PLASMA; 24S-HYDROXYCHOLESTEROL; BIOSYNTHESIS PATHWAY; EXPRESSION; DYSFUNCTION; METABOLISM; MANIFEST;
D O I
10.1038/cdd.2014.162
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the adult brain, neurons require local cholesterol production, which is supplied by astrocytes through apoE-containing lipoproteins. In Huntington's disease (HD), such cholesterol biosynthesis in the brain is severely reduced. Here we show that this defect, occurring in astrocytes, is detrimental for HD neurons. Astrocytes bearing the huntingtin protein containing increasing CAG repeats secreted less apoE-lipoprotein-bound cholesterol in the medium. Conditioned media from HD astrocytes and lipoprotein-depleted conditioned media from wild-type (wt) astrocytes were equally detrimental in a neurite outgrowth assay and did not support synaptic activity in HD neurons, compared with conditions of cholesterol supplementation or conditioned media from wt astrocytes. Molecular perturbation of cholesterol biosynthesis and efflux in astrocytes caused similarly altered astrocyte-neuron cross talk, whereas enhancement of glial SREBP2 and ABCA1 function reversed the aspects of neuronal dysfunction in HD. These findings indicate that astrocyte-mediated cholesterol homeostasis could be a potential therapeutic target to ameliorate neuronal dysfunction in HD.
引用
收藏
页码:690 / 702
页数:13
相关论文
共 50 条
  • [41] Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem Cells
    Ring, Karen L.
    An, Mahru C.
    Zhang, Ningzhe
    O'Brien, Robert N.
    Ramos, Eliana Marisa
    Gao, Fuying
    Atwood, Robert
    Bailus, Barbara J.
    Melov, Simon
    Mooney, Sean D.
    Coppola, Giovanni
    Ellerby, Lisa M.
    STEM CELL REPORTS, 2015, 5 (06): : 1023 - 1038
  • [42] Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene
    O'Kusky, JR
    Nasir, J
    Cicchetti, F
    Parent, A
    Hayden, MR
    BRAIN RESEARCH, 1999, 818 (02) : 468 - 479
  • [43] Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease
    Yang, Dun-Sheng
    Kumar, Asok
    Stavrides, Philip
    Peterson, Jesse
    Peterhoff, Corrine M.
    Pawlik, Monika
    Levy, Efrat
    Cataldo, Anne M.
    Nixon, Ralph A.
    AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (03): : 665 - 681
  • [44] Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease
    Lian, Hong
    Litvinchuk, Alexandra
    Chiang, Angie C. -A.
    Aithmitti, Nadia
    Jankowsky, Joanna L.
    Zheng, Hui
    JOURNAL OF NEUROSCIENCE, 2016, 36 (02): : 577 - 589
  • [45] Disruption of Calcium Signaling Is Necessary for Ectopic Neuronal Cell Cycle Reentry and Subsequent Neuron Death in Alzheimer's Disease.
    Kodis, E. J.
    Bloom, G. S.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [46] Game-changer in the fight against Huntington's disease: Cholesterol nanoparticles restore brain function in mice
    Martin, Mauricio G.
    Dotti, Carlos G.
    PHARMACOLOGICAL RESEARCH, 2023, 194
  • [47] Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats
    Kantor, Orsolya
    Temel, Yasin
    Holzmann, Carsten
    Raber, Kerstin
    Nguyen, Huu-Phuc
    Cao, Chunyan
    Turkoglu, Hatice Ozen
    Rutten, Bart P. F.
    Visser-Vandewalle, Veerle
    Steinbusch, Hany W. M.
    Blokland, Arjan
    Korr, Hubert
    Riess, Olaf
    von Hoersten, Stephan
    Schmitz, Christoph
    NEUROBIOLOGY OF DISEASE, 2006, 22 (03) : 538 - 547
  • [48] NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: Implications for Huntington's disease
    Napolitano, Maddalena
    Zei, Daniela
    Centonze, Diego
    Palermo, Rocco
    Bernardi, Giorgio
    Vacca, Alessandra
    Calabresi, Paolo
    Gulino, Alberto
    NEUROSCIENCE LETTERS, 2008, 434 (03) : 241 - 246
  • [49] Mutant Huntingtin accumulation in the nucleus affects nucleolar function in Huntington's disease mouse models and patients at early stages
    Soenmez, A.
    Spieth, S.
    Mustafa, R.
    Kojer, K.
    Litke, C.
    Kochi, J.
    Orth, M.
    Liss, B.
    Parlato, R.
    ACTA PHYSIOLOGICA, 2019, 227
  • [50] Global alteration in postganglionic neuronal function affects whole body kinetics of MIBG in patients with Parkinson's disease
    di Poggio, M. Bandettini
    Morbelli, S.
    Marini, C.
    Marchese, R.
    Pomposelli, E.
    Avanzino, L.
    Sambuceti, G.
    Abbruzzese, G.
    MOVEMENT DISORDERS, 2009, 24 : S317 - S318